ZA978602B - Novel NMDA (N-methyl-D-aspartate) antagonists. - Google Patents

Novel NMDA (N-methyl-D-aspartate) antagonists.

Info

Publication number
ZA978602B
ZA978602B ZA9708602A ZA978602A ZA978602B ZA 978602 B ZA978602 B ZA 978602B ZA 9708602 A ZA9708602 A ZA 9708602A ZA 978602 A ZA978602 A ZA 978602A ZA 978602 B ZA978602 B ZA 978602B
Authority
ZA
South Africa
Prior art keywords
aspartate
antagonists
methyl
novel nmda
nmda
Prior art date
Application number
ZA9708602A
Other languages
English (en)
Inventor
Boyd L Harrison
Bruce M Baron
Raymond S Gross
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ZA978602B publication Critical patent/ZA978602B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9708602A 1996-09-30 1997-09-25 Novel NMDA (N-methyl-D-aspartate) antagonists. ZA978602B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72317596A 1996-09-30 1996-09-30

Publications (1)

Publication Number Publication Date
ZA978602B true ZA978602B (en) 1998-03-30

Family

ID=24905175

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708602A ZA978602B (en) 1996-09-30 1997-09-25 Novel NMDA (N-methyl-D-aspartate) antagonists.

Country Status (18)

Country Link
EP (1) EP0929521B1 (ko)
JP (1) JP2001501221A (ko)
KR (1) KR20000048715A (ko)
CN (1) CN1139572C (ko)
AR (1) AR009374A1 (ko)
AT (1) ATE309215T1 (ko)
AU (1) AU732997B2 (ko)
BR (1) BR9712144A (ko)
CA (1) CA2266556C (ko)
DE (1) DE69734594T2 (ko)
DK (1) DK0929521T3 (ko)
HU (1) HUP0000882A3 (ko)
IL (1) IL129187A0 (ko)
NO (1) NO314080B1 (ko)
NZ (1) NZ334343A (ko)
TW (1) TW492958B (ko)
WO (1) WO1998014427A1 (ko)
ZA (1) ZA978602B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010053849A1 (en) * 1999-06-16 2001-12-20 Mary Jeanne Kreek Plural biological sample arrays, and preparation and uses thereof
US6825203B2 (en) 2000-04-28 2004-11-30 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
HU227197B1 (en) 2000-10-24 2010-10-28 Richter Gedeon Nyrt Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
US7820688B2 (en) 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
WO2003039540A2 (en) * 2001-11-09 2003-05-15 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
DE10306202A1 (de) * 2003-02-13 2004-08-26 Grünenthal GmbH Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
MX2010004402A (es) * 2007-10-22 2010-10-15 Orchid Res Lab Ltd Inhibidores de histona deacetilasa.
CA2788656A1 (en) 2010-02-16 2011-08-25 Pfizer Inc. (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors
CA3146163A1 (en) 2019-07-08 2021-01-14 University Of Health Sciences & Pharmacy In St. Louis G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2088011T3 (es) * 1990-07-16 1996-08-01 Merrell Pharma Inc Antagonistas de aminoacidos excitadores.
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
WO1994027964A1 (en) * 1993-05-27 1994-12-08 Merrell Dow Pharmaceuticals Inc. 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
GB9319243D0 (en) * 1993-09-17 1993-11-03 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
ATE309215T1 (de) 2005-11-15
TW492958B (en) 2002-07-01
NO314080B1 (no) 2003-01-27
NO991533D0 (no) 1999-03-29
AR009374A1 (es) 2000-04-12
AU4071897A (en) 1998-04-24
AU732997B2 (en) 2001-05-03
CN1139572C (zh) 2004-02-25
NZ334343A (en) 2001-01-26
CN1232452A (zh) 1999-10-20
EP0929521A1 (en) 1999-07-21
HUP0000882A3 (en) 2001-04-28
NO991533L (no) 1999-05-28
BR9712144A (pt) 1999-08-31
WO1998014427A1 (en) 1998-04-09
HUP0000882A2 (hu) 2000-09-28
CA2266556C (en) 2007-11-06
JP2001501221A (ja) 2001-01-30
DE69734594T2 (de) 2006-07-06
CA2266556A1 (en) 1998-04-09
IL129187A0 (en) 2000-02-17
DK0929521T3 (da) 2006-03-27
DE69734594D1 (en) 2005-12-15
KR20000048715A (ko) 2000-07-25
EP0929521B1 (en) 2005-11-09

Similar Documents

Publication Publication Date Title
ZA985678B (en) 1-amino-alkylcyclohexane NMDA receptor antagonists.
CY2410B1 (en) Novel device.
HU9603082D0 (en) Neurokinine (tachykinine) antagonists
ZA977086B (en) NAALADase inhibitors.
ZA96940B (en) Substituted biphenyl sulfonamide edothelin antagonists.
ZA972056B (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives.
ZA996133B (en) Substituted benzamides.
AP9801212A0 (en) Tetrahydroquin olinesas NMDA antagonists
ZA987055B (en) Substituted 4-benzoylpyrazoles.
ZA987058B (en) Substituted 4-benzoylpyrazoles.
ZA978602B (en) Novel NMDA (N-methyl-D-aspartate) antagonists.
ZA97928B (en) Novel heteroaryl-oxazolidinones.
HK1031025A1 (en) Disk apparatus.
ZA972944B (en) Novel retinoids.
ZA971184B (en) Endothelin antagonists.
ZA974052B (en) New benzothiazolinones.
ZA973537B (en) Novel sulfonylurea compounds.
ZA9810554B (en) A dehusking apparatus.
ZA987B (en) Substituted 4-benzoylpyrazoles.
ZA974056B (en) New thiazolopyridines.
ZA984307B (en) A slide apparatus.
ZA983795B (en) Substituted 4-benzoyl-pyrazoles.
ZA9711057B (en) Process for the preparation of nmda antagonists.
ZA989435B (en) Novel aryloxy-alkyl-dialkylamines.
ZA9811829B (en) Line testing.